I n this issue of Circulation Research, Gregoire et al 1 report their discovery that Yin-Yang 1 (YY1) is a critical factor for the transition from cardiac progenitor to differentiated cardiomyocyte. The authors made clever use of currently available transcription factor (TF)-binding databases to perform a bioinformatic-based screen for factors regulating cardiac progenitor genes. They compared their data set of genes enriched in mouse embryonic stem (ES) cell-derived cardiac progenitor cells (CPCs) with freely available TF-binding databases. They initially screened 32 candidate TFs and, surprisingly, found that YY1, a known repressor of sarcomeric gene expression, is resident on many CPC genes.
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The heart is the first organ to develop in the vertebrate embryo. Precardiogenic mesoderm is initially derived from anterior lateral plate mesoderm. Signals from surrounding tissues promote lateral plate to form cardiogenic mesoderm by inducing a cardiogenic transcriptional network. The cardiogenic mesoderm contains CPCs that differentiate into primitive cardiomyocytes. The transition from CPCs to cardiomyocytes is a critical developmental transition point that needs further study and is the focus of the study by Gregoire. Importantly, the cardiogenic developmental process can be mimicked by conversion of ES cells into CPCs and then into cardiomyocytes. ES-derived cardiomyocytes have been used to identify factors regulating heart development and have the added advantage of potentially becoming a source of cells in regenerative cell therapies.
Like the cardiac lineage in embryos, murine ES cell-derived CPCs express one of the earliest cardiac genes, the Nkx2.5 TF. Although Nkx2.5 is the mammalian ortholog of tinman, which acts as a master regulator of cardiac development in Drosophila, Nkx2.5 itself is insufficient to promote cardiogenic development. Commitment of early embryonic mesoderm to the cardiac lineage requires signaling molecules, such as bone morphogenetic protein and Activin, to activate expression or function of numerous TFs in addition to Nkx2.5. 2 Gregoire et al 1 now report that YY1 is an essential component of the transcriptional loop regulating early heart development. YY1 is a member of the Gli-Kruppel family of zinc finger proteins and, as its name implies, shows context-dependent activity. YY1 was first cloned as a factor that regulates activity of the adeno-associated virus promoter. 3 Expressed ubiquitously, YY1 regulates a wide array of biological processes often by modulating transcription in divergent ways. In some contexts, YY1 functions as a repressor, whereas in others it is an activator. The ability of YY1 to recruit both activators and repressors of transcription accounts for its contextual functions.
During transcriptional repression, YY1 physically interacts with histone deacetylaces to repress gene transcription and prevent cardiac hypertrophy. 4 In muscle gene regulation, YY1 forms a complex with the EZH2 methyltransferase, a component of the polycombe repressor complex, and histone deacetylace 1 to repress gene expression. 5 Recent work has also shown that YY1 recruits the Xist noncoding RNA to the X inactivation center during X chromosome inactivation, indicating that YY1 is also an RNA-binding protein. 6 In contrast, during transcriptional activation, YY1 can directly interact with the histone acetyltransferase, P300, to enhance histone acetylation and thereby enhance gene expression. 3 YY1 also recruits PRMT1, a Histone H4 (Arg3) methyltransferase, to YY1 regulatory elements, and this also promotes transcription 7 (Figure) .
In this article, the authors show that YY1 acts as a transcriptional activator to promote both Nkx2.5 expression and CPC commitment. Using a combination of in vitro luciferasebased assays, in vivo chromatin immunoprecipitation (ChIP) and genomewide sequencing analysis, the authors delineated a 2.1-kb cardiac-specific enhancer element that recruits YY1 to enhance Nkx2.5 transcription. In addition, they show that YY1 function during CPC commitment is through a partnership with Gata4, a TF essential for early heart development. Furthermore, the authors show that the overexpression of YY1 enhanced the cardiogenic differentiation of ES cells into CPCs in vitro using an ES cell-based assay. Finally, cardiac mesoderm-specific YY1 loss-of-function resulted in early embryonic lethality.
One of the experiments used by Gregoire is ChIP-sequencing (ChIP-seq), an approach that allows analysis of chromatin-binding sites on a genomewide scale. ChIP-seq requires massively parallel sequencing that is becoming cheaper to perform as new technologies continue to be developed. Because of its unbiased nature, ChIP-seq has the potential to provide powerful new information about transcriptional regulation. ChIP-seq has already been used to provide insight into TF-binding sites throughout the genome in multiple contexts. 8 There are limitations to the data presented by Gregoire. Although CPCs derived from ES cells are useful for working out mechanisms, it is nonetheless an artificial system that requires in vivo validation. Although Gregoire performed considerable in vivo validation, further work in the embryo will be necessary to completely validate the model. A related limitation of the genomewide approaches, such as ChIP-seq, is that it fails to provide 3-dimensional, spatial information Figure. Conceptual model of Yin-Yang 1 (YY1) and GATA4 transcriptional activation of Nkx2-5. The YY1-and GATA4binding domain has been mapped to a 2.1-kb region upstream of the Nkx2-5 promotor. Additionally, T-box transcription factor 5 (TBX5)-and serum response factor (SRF)-binding motifs are located near the YY1-and GATA binding protein 4 (GATA4)binding domain. PRMT1 and p300 are known transcription coactivators of YY1. Other potential targets of YY1 transcriptional activation include Pitx2, Tbx3, Tbx5, and Mef2c.
